They primarily function through two mechanisms: first, by improving the TME, which enhances the activity and functionality of immune cells by reducing the accumulation of inflammatory factors and cells; second, by augmenting the anti-tumor immune response and activating the immune system to release cytokines such as IFN-γ and IL-2, thereby inhibiting tumor growth and metastasis. The gene discussed is IL2; the disease is neoplasm.